Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron for Fibromyalgia (Randomized, Double-Blind, Placebo-Controlled)
KCT0002651Phase 3Recruiting
- Sponsor
- Astellas Pharma
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fibromyalgia (FM) comparing Ramosetron with Placebo (2 arms). Started Aug 2017; status: recruiting.
02
Drugs
ramosetron
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on KCT0002651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002651.